Teva Pharmaceutical (NYSE: TEVA) stock rose approximately 12.3% last week. The surge was primarily attributed to the company's second-quarter report, which showed sales of $4.1 billion, surpassing average analyst targets by roughly $70 million, and a softer-than-expected year-over-year revenue decline.
Additionally, Teva announced plans for a direct listing of its common stock on the New York Stock Exchange (NYSE), replacing its American Depositary Receipts (ADRs) starting September 14. This move is expected to attract institutional investors and retail traders.
Teva Pharmaceutical stock surged 12.3% last week, driven by better-than-expected Q2 sales and planned NYSE direct listing
Source:Yahoo财经 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Iran-linked exchange Shelbit allegedly sent $676 million to Binance in sanctions-evasion operation, Reuters reports
-
2
Analysis Compares Healthcare ETFs: Invesco Nasdaq Biotech ETF (IBBQ) Saw 45.5% One-Year Return, Outperforming State Street Healthcare Select Sector SPDR ETF (XLV)
-
3
Analysis: Vanguard Small-Cap Growth ETF (VBK) up 21% YTD 2026, Outperforming Large-Cap Growth ETF (VONG) at 0.3% YTD
-
4
What Is POLA? Background and Investment Risk Analysis of the Pola On Base Project
-
5
Claiming Social Security benefits at age 62 instead of 67 can reduce monthly payments by 30%, potentially costing average retirees $150,000 over 20 years.
-
6
What Is DuckChain (DUCK)? An Analysis of Its Future Prospects
-
7
Analysis: Roundhill N-100 0DTE Covered Call ETF (QDTE) Payouts May Include Return of Capital, Trailing Nasdaq-100 Performance
-
8
The Future of Wrapped Bitcoin (WBTC): Bitcoin’s Role as a Bridge and the Challenges It Faces in the Ethereum DeFi Ecosystem
-
9
Analysis: Robinhood (HOOD) Stock Down 43% From High, Q2 Revenue Up 32% YoY Driven by Prediction Markets and Equities Trading
-
10
BNB (BNB) is increasingly becoming a key component of cryptocurrency index funds and ETFs.
Markets Today
Recommended Reading






